CC-95251 is a monoclonal antibody that targets CD47-SIRPα on the surface of tumor cells. It is in development for use in several different cancers.
| SparkCures ID | 625 |
|---|---|
| Generic Name | CC-95251 |
| Additional Names | BMS-986351, Anzurstobart |
| Treatment Classifications | |
| Treatment Targets |
There are no resources, links or videos to display for this treatment.